Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment
Elena Verdugo, Iker Puerto, Miguel Ángel Medina
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1083-1111
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 66
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 64
An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma
Silvia Mara Baez Rodriguez, A. El Kamel, Gheorghe Vasile Ciubotaru, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11110-11110
Open Access | Times Cited: 47
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
Zhong Lan, Xin Li, Xiao-Qin Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3040-3040
Open Access | Times Cited: 35
IDO1 inhibits ferroptosis by regulating FTO-mediated m6A methylation and SLC7A11 mRNA stability during glioblastoma progression
Qianting Tian, Guixue Dan, Xuyan Wang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Transferrin receptor 1 targeted nanomedicine for brain tumor therapy
Jianru Li, Zixia Zhang, Baoli Zhang, et al.
Biomaterials Science (2023) Vol. 11, Iss. 10, pp. 3394-3413
Closed Access | Times Cited: 28
Targeted Glioma Therapy—Clinical Trials and Future Directions
A. B. Shikalov, Igor Koman, Natalya M. Kogan
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 100-100
Open Access | Times Cited: 12
CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma
Jixing Zhao, Xiaoteng Cui, Zhan Qi, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2835-2855
Open Access | Times Cited: 10
GAS41 promotes ITGA4-mediated PI3K/Akt/mTOR signaling pathway and glioma tumorigenesis
Guanglei Shang, Wenju Zhang, Yanjie Jia, et al.
Biochemical Pharmacology (2025), pp. 116747-116747
Closed Access | Times Cited: 1
Emerging nanoplatforms towards microenvironment-responsive glioma therapy
Nigam Sekhar Tripathy, Liza Sahoo, Safal Kumar Paikray, et al.
Medical Oncology (2025) Vol. 42, Iss. 2
Closed Access | Times Cited: 1
PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications
Francisco Aguayo, Francisco Perez-Dominguez, Julio Osorio, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 672-672
Open Access | Times Cited: 22
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma
Xiaoteng Cui, Jixing Zhao, Guanzhang Li, et al.
Cancer Communications (2023) Vol. 43, Iss. 12, pp. 1326-1353
Open Access | Times Cited: 20
Viruses in glioblastoma: an update on evidence and clinical trials
Bavani Gunasegaran, Caroline L. Ashley, Felix Marsh‐Wakefield, et al.
BJC Reports (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 8
Glut-3 Gene Knockdown as a Potential Strategy to Overcome Glioblastoma Radioresistance
Gaia Pucci, Luigi Minafra, Valentina Bravatà, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2079-2079
Open Access | Times Cited: 7
Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock
Nina Nelson, Angela Relógio
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Intraoperative ultrasound for surgical resection of high-grade glioma and glioblastoma: a meta-analysis of 732 patients
Pavel S. Pichardo-Rojas, Carlos A. Zarate, Julieta Arguelles-Hernández, et al.
Neurosurgical Review (2024) Vol. 47, Iss. 1
Closed Access | Times Cited: 6
Camouflaging multifunctional nanoparticles with bacterial outer membrane for augmented chemodynamic/photothermal/starvation/chemo multimodal synergistic therapy of orthotopic glioblastoma
Yichen He, Yi Pan, Xin Zhao, et al.
Chemical Engineering Journal (2023) Vol. 471, pp. 144410-144410
Closed Access | Times Cited: 15
The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway
Junjun Chen, Tianzhu Lu, Tao Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 6
FOXP3 promote the progression of glioblastoma via inhibiting ferroptosis mediated by linc00857/miR-1290/GPX4 axis
Wenpeng Cao, HE Ya, Jinzhi Lan, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 5
Association between the Anatomical Location of Glioblastoma and Its Evaluation with Clinical Considerations: A Systematic Review and Meta-Analysis
Juan José Valenzuela-Fuenzalida, Laura Moyano-Valarezo, Vicente Silva-Bravo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3460-3460
Open Access | Times Cited: 5
The combination of temozolomide and perifosine synergistically inhibit glioblastoma by impeding DNA repair and inducing apoptosis
Wenpeng Zhao, Liwei Zhou, Wentao Zhao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Alkaloid-Based Modulators of the PI3K/Akt/mTOR Pathway for Cancer Therapy: Understandings from Pharmacological Point of View
Fatima Zohra Mokhfi, Md. Al Amin, Mehrukh Zehravi, et al.
Chemico-Biological Interactions (2024) Vol. 402, pp. 111218-111218
Closed Access | Times Cited: 5
From Theory to Practice: Implementing the WHO 2021 Classification of Adult Diffuse Gliomas in Neuropathology Diagnosis
Karina Chornenka Martin, Crystal Ma, Stephen Yip
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 817-817
Open Access | Times Cited: 12
Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment
Mahdie Rahban, Sara Joushi, Hamideh Bashiri, et al.
Frontiers in Chemistry (2024) Vol. 11
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top